Imprint cytology predicts axillary node status in sentinel lymph node biopsy

Ulster Medical Journal

Volumn 79, Issue 3, 2010, Pages 119-122

  Bell, Zarina ^b   Cameron, Iain ^a   Stephen Dace, J ^b  

^a Departments of General Surgery and Pathology   (United Kingdom)

^b ALTNAGELVIN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER INVASION; CANCER SIZE; CLINICAL TRIAL; CYTOLOGY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; PREDICTION; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

AXILLA; CYTODIAGNOSIS; CYTOLOGICAL TECHNIQUES; FEMALE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 78649802315     PISSN: 00416193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Fleissig A, Fallowfeld LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat. 2006; 95(3):279-3.
2. Sentinel Lymph Node Biopsy Handbook - New Start. London: Royal College of Surgeons of England; 2004.
3. Vijayakumar V Boerner PS, Jani AB, Vijayakumar S. A critical review of variables affecting the accuracy and false-negative rate of sentinel node biopsy procedures in early breast cancer. Nucl Med Comm. 2005; 26(5):395-405
4. Kaleya RN, Heckman JT, Most M, Zager JS. Lymphatic mapping and sentinel node biopsy: a surgical perspective. Semin Nucl Med. 2005; 35(2):129-134
5. Clarke D, Khonji NI, Mansel RE. Sentinel node biopsy in breast cancer: ALMANAC trial. World J. Surg. 2001; 25(6):819-22
6. Aarsvold JN, Alazraki NP. Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med. 2005; 35(2):116-28
7. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer - a multicentre validation study. N Engl J Med. 1998; 339(14):941-6.
8. Tew K, Irwig L, Matthews A, Crowe P, Macaskill P. Meta-analysis of sentinel node imprint cytology in breast cancer. British Journal of Surgery 2005; 92(9):1068-80
9. Hamidian JA, Narayanan S, MacNeill F, Osin P, Nerurkar A, Gui G. Testing the feasibility of intra-operative sentinel lymph node touch imprint cytology. Ann R Coll Surg Engl. 2009; 91(4):336-9
10. Scucchi LF, Di Stefano D, Cosetino L, Vecchione A. Value of cytology as an adjunctive intraoperative diagnostic method. An audit of 2250 consecutive cases. Acta Cytol. 1997; 41(5):1489-96
11. Hansen NM, Grube B, Ye X, Turner RR, Brenner RJ, Sim MS, et al: Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol. 2009; 27(28):4679-84.
12. Ludwig Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet. 1990; 335(8705):1565-68
13. De Boer M, van Deurzen CH, van Dijck JA, Borm GF, van Diest PJ, AdangEM, etal:Micrometastasesorisolatedtumorcells and the outcome of breast cancer. N Engl J Med. 2009 361(7):653-63